Skip to main content
PI

PerSapien Innovations

PerSapien develops Airlens, a device designed to protect individuals from air pollution. Airlens aims to mitigate the health risks associated with environmental air quality.

Founded 201761K+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Air pollution poses significant health risks, especially in urban environments and enclosed spaces like vehicles, exposing individuals to harmful particulate matter, germs, bacteria, odors, and pollen. Existing air purification solutions may be inefficient, expensive, or unable to provide comprehensive protection against a wide range of airborne contaminants.

Solution

PerSapien develops Airlens, a suite of air purification products designed to protect individuals from airborne pollutants and pathogens. Airlens utilizes Active Molecular Technology (AMT) to eliminate PM2.5, PM10, germs, bacteria, odors, and pollen, creating WHO-level air quality. The product line includes a car air sanitizer that cleans the air inside vehicles, as well as personal protection devices like the Airlens N99 mask, offering comparable performance to higher-priced alternatives. PerSapien's solutions aim to make effective air purification accessible and affordable, addressing the root causes of airborne health hazards.

Target Audience

The primary target audience includes individuals concerned about air quality in urban environments, vehicle owners seeking in-car air purification, and health-conscious consumers looking for affordable and effective personal protective equipment.

Features

  • Active Molecular Technology (AMT) for broad-spectrum air purification
  • Airlens Car Air Sanitizer: Removes PM2.5, PM10, germs, bacteria, odors, and pollen inside vehicles
  • Airlens N99 Mask: Provides high-efficiency filtration at an affordable price
  • Solutions developed by scientists from IIT, AIIMS, and Stanford University
  • Vehicle exhaust mounted air purification device (Minus 2.5)
This profile is AI-generated and may contain inaccuracies.